Stock price when the opinion was issued
Tremendous job filling units since pandemic, occupancy back to near 90%. Leading edge of baby boomer population starting to access this type of product. Discount to NAV. Making great accretive acquisitions, so he expects NAV growth. Great product, high-margin business. Yield is 3.9%.
(Analysts’ price target is $16.96)Of all the long-term care facilities, this would be the one she'd look at the closest. Secular trend of aging demographics isn't going away. Targeting 95% occupancy, which is achievable. Liability risk if another Covid-type outbreak. Healthcare worker shortage. Yield is less than 4%.
See her Top Picks for a name that plays to the same demographic.
We note that it has been one of the best performing REITs over the past two years amidst broad sector weakness. The Trust has managed to navigate the high-rate environment and execute its acquisitive growth strategy with 2024 being a record year. Unit prices have appreciated significant to where it is quite expensive from a valuation standpoint, but there are plenty of positive fundamental trends, with increasing occupancy rates, fund flows, and margins. We like its recent momentum, and its distribution is well-covered by cash flows. It is not exactly cheap, trading at 3.7X book, but its FFO interest coverage ratio and FFO/debt have all been increasing, showing a positive trend in profitability. We would be comfortable buying here for an income name.
Unlock Premium - Try 5i Free
They're the best Canadian operator in this space, but there are many sophisticated private ones as well. The competition is fierce. Also, it will get harder to staff these places. Thirdly, there's the uncertainty over interest rates. He looked at during the pandemic and knew it would do well after the pandemic, but passed for these reasons. CSH has done well since then and will continue to do well, but isn't sure what will drive it much higher. It's a steady eddy, a good company, but unfortunately one he passed on.